UNSPSC 51191552: Hydroxindasate

This classification denotes a diuretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8687J667P. European Medicines Agency schedules Hydroxindasate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08072MIG. Hydroxindasate generally arises in the molecular formula C21H24N2O3. The term HYDROXINDASATE is an International Non-Proprietary Name or INN. HYDROXINDASATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule hydroxindasate under HS 29339990 and SITC 51577. As of Q4 2014, HYDROXINDASATE remains the US FDA Preferred Term for this commodity. Hydroxindasate bears US NLM identifiers UMLS ID C1881075 and NCI Concept Code C65866. SMILES: O(C1CC2C(C(N(C2CC1)CC1CCC(OC)CC1)C)CCN)C(=O)C.

UNSPSC 51191552 Hydroxindasate, a Commodity code, encompasses chemical supply products for municipal water treatment and healthcare operations, though recent state and local solicitations under this code show substantial divergence from the nominal classification. State and local governments procure chemical commodities — primarily sodium bisulfite and pharmaceutical products — through direct municipal IFBs and multistate cooperative purchasing vehicles. The City of Meriden and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the issuing-body mix: municipal utilities managing water pollution control alongside multistate health and procurement consortia aggregating demand across participating jurisdictions. Chemical suppliers and pharmaceutical manufacturers dominate respondent profiles, with insurance and bonding requirements (General Liability of $1,000,000 to $5,000,000, depending on scope) and compliance certifications (cGMP, DSCSA for pharmaceuticals; product-quality standards for chemicals) as standard contract prerequisites.

Geographic activity spans Connecticut and Minnesota as primary anchors in recent solicitations. The City of Meriden issued IFB B027-15 for sodium bisulfite delivery to its Water Pollution Control Facility with a due date of July 29, 2026, structured on unit-cost pricing with firm pricing and performance and payment bond requirements. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products on behalf of participating state and local government facilities including Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026; the RFP weights price competitiveness at 75 percent and mandates three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health 110 and 112, Morris & Dickson Co., LLC) and a 3 percent administrative fee on all purchases. The code shows limited recent activity with significant commodity-classification mismatch between hydroxindasate nomenclature and the water treatment chemicals and pharmaceuticals actually being procured.